Description
Epithalon is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG), developed by Professor Vladimir Khavinson as the defined synthetic analog of epithalamin — a polypeptide extracted from bovine pineal gland tissue. It is the most extensively studied compound in the Khavinson bioregulator series, with over three decades of preclinical data across telomere biology, pineal neuroendocrine regulation, and cellular aging models. Its primary research interest centers on telomerase activation in somatic cells — specifically hTERT upregulation and telomere elongation in cell culture models — placing it at the intersection of epigenetics, circadian physiology, and cellular aging research. Researchers studying Epithalon work within the specialty research peptide class of compounds defined by intranuclear gene regulatory mechanisms rather than cell-surface receptor binding.
Key Characteristics
- Activates hTERT (human telomerase reverse transcriptase) in somatic cell cultures — Khavinson et al. documented telomere elongation and extended replicative capacity beyond the Hayflick limit in human fetal fibroblasts without signs of malignant transformation, which is the specific finding that distinguishes this research from simple proliferative stimulation
- Pineal gland origin connects Epithalon to melatonin rhythm regulation — preclinical data documents normalization of melatonin secretion patterns in aged animal models, making it relevant in circadian biology research alongside its telomere-focused applications
- Operates through the same intranuclear DNA-binding mechanism as other Khavinson bioregulators, with AEDG proposed to interact with hTERT gene promoter regions — unlike MOTS-c, which targets mitochondrial-nuclear retrograde signaling through AMPK activation, Epithalon’s cellular aging research angle is chromosomal rather than metabolic
- Antioxidant enzyme activity — specifically superoxide dismutase and catalase upregulation — has been documented in preclinical models, connecting Epithalon research to oxidative stress biology independently of its telomerase effects
- Note on spelling: Epithalon and Epitalon refer to the same compound — both spellings appear in the scientific literature, with Epitalon more common in Russian-language publications and Epithalon in Western vendor and research contexts
Handling and Storage
Store as lyophilized powder under refrigeration, away from heat, moisture, and light. Reconstitute immediately before use and avoid repeated freeze-thaw cycles to maintain peptide integrity across experimental batches.
FAQs
What is Epithalon?
Epithalon (AEDG) is a synthetic tetrapeptide bioregulator derived from pineal gland tissue research, developed by Professor Khavinson as the defined synthetic analog of epithalamin. It is studied primarily for hTERT upregulation and telomere elongation in somatic cell cultures, and secondarily for its effects on melatonin rhythm normalization and antioxidant enzyme activity in preclinical aging models. All evidence is preclinical; no approved therapeutic applications exist.
How does Epithalon’s telomerase research differ from general proliferation studies?
The critical distinction in the published data is that telomere elongation was observed without malignant transformation or karyotypic abnormality in cell culture models. Most proliferative stimuli raise concerns about oncogenic potential — Epithalon’s research value in telomere biology specifically is that the extended replicative capacity documented by Khavinson et al. maintained normal cellular morphology throughout, which is the finding that makes it mechanistically interesting rather than simply a growth-promoting compound.
How does Epithalon relate to N-Acetyl Epithalon Amidate?
N-Acetyl Epithalon Amidate is a modified version of Epithalon with N-terminal acetylation and C-terminal amidation — structural changes that improve proteolytic stability and alter the peptide’s degradation profile compared to the unmodified AEDG sequence. Researchers select between them based on whether the study requires the native sequence for direct comparison with published Khavinson data, or improved stability for longer-duration experimental protocols.
